+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "High Content Screening"

From
From
From
From
From
High End Cellomics Market Report 2026 - Product Thumbnail Image

High End Cellomics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
High End Cellomics Market - Global Strategic Business Report - Product Thumbnail Image

High End Cellomics Market - Global Strategic Business Report

  • Report
  • July 2026
  • 212 Pages
  • Global
From
From
From
From
From
Cell Culture Plasticware Market Report 2026 - Product Thumbnail Image

Cell Culture Plasticware Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Drug Discovery Outsourcing Market - Global Forecast 2026-2032 - Product Thumbnail Image

Drug Discovery Outsourcing Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Loading Indicator

High Content Screening (HCS) is a biotechnology technique used to analyze and quantify the effects of drugs, chemicals, and genetic modifications on cells. It is a powerful tool for drug discovery and development, as well as for basic research. HCS combines automated microscopy, image analysis, and data management to provide a comprehensive view of cellular responses. It can be used to measure a variety of cellular parameters, including cell morphology, protein expression, and gene expression. HCS is used in a variety of applications, including drug discovery, toxicity testing, and stem cell research. It is also used to study the effects of environmental factors on cells, such as temperature, pH, and light. HCS is becoming increasingly important in the biotechnology industry, as it allows researchers to quickly and accurately analyze large amounts of data. Some companies in the HCS market include Thermo Fisher Scientific, PerkinElmer, GE Healthcare, BioTek Instruments, and Olympus. Show Less Read more